Patients with atrial fibrillation and at moderate to high risk of stroke were randomly assigned in a 1:1:1 ratio to receive warfarin , dose adjusted to an international normalised ratio of 20-30 , higher-dose edoxaban ( 60 mg once daily ) , or lower-dose edoxaban ( 30 mg once daily ) .